Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Interest Coverage Ratio (2016 - 2017)

Heron Therapeutics filings provide 4 years of Interest Coverage Ratio readings, the most recent being 492.99 for Q1 2017.

  • On a quarterly basis, Interest Coverage Ratio fell 47.99% to 492.99 in Q1 2017 year-over-year; TTM through Dec 2017 was 1945.58, a 2760.63% decrease, with the full-year FY2025 number at 0.26, up 86.17% from a year prior.
  • Interest Coverage Ratio hit 492.99 in Q1 2017 for Heron Therapeutics, down from 36.85 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 36.85 in Q4 2016 to a low of 492.99 in Q1 2017.
  • Median Interest Coverage Ratio over the past 3 years was 120.88 (2013), compared with a mean of 174.85.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 660.75% in 2013 and later plummeted 47.99% in 2017.
  • Heron Therapeutics' Interest Coverage Ratio stood at 60.59 in 2013, then surged by 39.18% to 36.85 in 2016, then tumbled by 1237.73% to 492.99 in 2017.
  • The last three reported values for Interest Coverage Ratio were 492.99 (Q1 2017), 36.85 (Q4 2016), and 53.88 (Q3 2016) per Business Quant data.